Treatment – The Bloodline with LLS

Join us as we speak to Dr. Benjamin Lampson of Dana-Farber Cancer Institute in Boston, MA. In Part One of this two-part series on mantle cell lymphoma (MCL), Dr. Lampson discusses the latest treatment advances for MCL. With more treatments available than just a few years ago, Dr. Lampson shares how his conversations with his patients have changed, providing more hope after a diagnosis of MCL.

Be sure to tune into Part 2 launching on May 23, 2022, where Dr. Lampson will focus on the exciting possibilities of CAR T-cell therapy for MCL.

Mentioned on this episode: 

• Mantle Cell Lymphoma
• Mantle Cell Mantle Cell Lymphoma (MCL) with Dr. Benjamin Lampson: What Patients Should Know episode
• LLS COVID Antibody Study and COVID resources
• Protecting Patients: COVID and Vaccine Updates episode
• Stem Cell Transplant
• Autologous Stem Cell Transplant
• Allogeneic Stem Cell Transplant
• Graft-vs-Host Disease
• Highlights from ASH conference

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• LLS Public Policy & Advocacy
• Clinical Trial Support Center
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy
• Survivorship Workbook

Support for this episode provided by Eli Lilly & Company.

Join us as we speak to Damion Davis, a myeloma patient and licensed professional counselor. In this episode, Damion talks about his myeloma diagnosis and how he reached remission after a stem cell transplant. Dealing with the difficulty of a cancer diagnosis as a husband and father of young daughters, Damion knew the benefits that therapy would provide for him and his family. In honor of Mental Health Awareness Month in May, we share his story of resilience, highlighting the importance of mental health care for cancer patients and their families. 

Mentioned on this episode: 

• Multiple Myeloma
• Stem Cell Transplant
• Autologous Stem Cell Transplant
• Parenting Resources
• Mental Health Resources
• Additional Mental Health and Crisis Resources
• Survivorship Workbook

Additional LLS Support Resources: 

• Information Specialists
• Financial support
• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Free booklets 
• LLS Public Policy & Advocacy
• Clinical Trial Support Center
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy

Support for this episode provided by Genentech, Inc & Biogen; GlaxoSmithKline; and Janssen Oncology.

Join us as we speak to Dr. Hongtao Liu and Dr. Adam DuVall from University of Chicago Medicine, about current and emerging cellular therapies for acute leukemias. These innovative therapies include CAR T-cell therapy, modified Natural Killer (NK) cells and stem cell transplantations. In this episode, we discuss how these groundbreaking therapies have changed the landscape of treatment for acute leukemias. The doctors share what they are excited about in the future, citing how clinical trials are advancing therapies and how cancer centers can better serve the unique needs of adolescent and young adults (AYAs) with acute leukemias by utilizing a holistic and comprehensive approach.

Mentioned on this episode: 

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• CAR T-cell Therapy
• Stem Cell Transplant
• Cellular Therapies
• Minimal/Measurable Residual Disease (MRD)
• Graft-Vs-Host Disease
• Adolescent and Young Adult (AYA) Oncology Program at University of Chicago
• CALMM Clinic at University of Chicago
• Young Adult Resources
• Survivorship Workbook
• Between Two Kingdoms

Additional LLS Support Resources: 

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Clinical Trial Support Center
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program 
• Free Nutrition Consultations

Support for this episode is provided by University of Chicago Medicine.

Bonus Content! Go to the Subscriber Lounge to see what Gregory has been up to since this episode in our new After the Podcast segment.

Join us as we speak to Gregory Proctor, a myeloma patient, and Erica Ali, the Senior Manager of Copay and Patient Financial Assistance Programs at The Leukemia & Lymphoma Society. In this episode, Gregory shares his story of his diagnosis with myeloma in July 2021 and how he has benefited from the LLS Copay Program, which provided financial support for his treatment. Erica discusses all of the financial programs that LLS has to support patients, what the funds cover, and how to apply for these programs. LLS Financial assistance improves patients’ access to care and is accessible to patients of all blood cancer diagnoses when funding is available.

Mentioned on this episode: 

• Multiple Myeloma
• Financial support
• Kut2ThaChase Podcast

Additional LLS Support Resources: 

• Free telephone/web patient programs 
• Patti Robinson Kaufmann First Connection Program
• Information Specialists
• Free booklets 
• LLS Public Policy & Advocacy
• Clinical Trial Support Center
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy

Join us as we speak to Dr. Peter Riedell and Dr. Benjamin Derman from University of Chicago Medicine, about the latest research coming out of the annual meeting of the American Society of Hematology (ASH). In this episode, we discuss new treatments on the horizon for lymphoma and myeloma. The doctors share how innovative therapies such as CAR T-cell therapy and new combinations of medicines are showing significant promise, providing further hope to patients.

Mentioned on this episode: 

• Lymphoma
• Myeloma
• Amyloidosis
• MGUS (Monoclonal Gammopathy of Undetermined Significance)
• Smoldering myeloma (Myeloma staging)
• Minimal/Measurable Residual Disease (MRD)
• Bispecific Antibody Therapy
• ASH Annual Meeting Highlights
• Anxiety and Hope: Living with CLL podcast episode
• Dara-KRd
• CAR T-cell Therapy
• Stem Cell Transplant
• Graft-Vs-Host Disease

Additional LLS Support Resources: 

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Clinical Trial Support Center
• Online chats 
• Young Adult Resources
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program Free Nutrition Consultations

Support for this episode is provided by University of Chicago Medicine.

Join us as we speak to Michelle Bratton, a registered dietitian and certified oncology nutritionist with LLS’s PearlPoint Nutrition Services®. In this episode, Michelle shares the benefits of nutrition throughout treatment and survivorship. Rather than cutting out foods, she changes the narrative for cancer patients by encouraging them to nourish their bodies. She also shares how a patient – or caregiver – with any cancer diagnosis, can take advantage of a free nutrition consultation to further guide them through their cancer experience.

Mentioned on this episode: 

• PearlPoint Nutrition Services®
• LLS Nutrition Information
• National Cancer Institute Nutrition Information 
• Eating Well Magazine

Additional LLS Support Resources: 

• Free telephone/web patient programs 
• Clinical Trial Support Center
• Patti Robinson Kaufmann First Connection Program
• Information Specialists
• Free booklets 
• Financial support
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Free Nutrition Consultations 
• LLS Advocacy
• LLS Myeloma Link

Support for this episode provided by Bristol Myers Squibb; Genentech, Inc. & Biogen; Pharmacyclics LLC, An AbbVie Company & Janssen Biotech, Inc.

Join us as we speak to Dr. Mariam Nawas and Dr. Satyajit Kosuri from University of Chicago Medicine, about graft-vs-host disease (GVHD) and the Transplant Optimization Program (TOP). In this episode, we discuss stem cell transplants, how GVHD occurs and what can be done to manage and treat symptoms. The doctors also share how the TOP program at the University of Chicago Medicine utilizes multiple specialties to improve post-transplant success for patients over 50.   

Mentioned on this episode: 

• Stem Cell Transplant
• Graft-Vs-Host Disease
• Barnes and Loutit Mouse Leukemia Study  
• University of Chicago Medicine Cancer Center
• Transplant Optimization Program (TOP)
• Be The Match

Additional LLS Support Resources: 

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Clinical Trial Support Center
• Online chats 
• Young Adult Resources
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program 
• Free Nutrition Consultations

Support for this episode is provided by University of Chicago Medicine.

Join us as we speak to Dr. Areej El-Jawahri, a physician researcher at Massachusetts General Hospital and Associate Professor of Medicine at Harvard Medical School. In this episode, Dr. El-Jawahri shares the wonderful benefits of palliative care for both blood cancer patients and their families. Often erroneously associated with hospice or end of life care, palliative care can be started at any point after diagnosis and has shown many benefits with being started early in treatment. In palliative care, the physical, emotional and cognitive challenges after a cancer diagnosis are addressed by a specialized team of providers, leading to a more comfortable experience through treatment and beyond.

Mentioned on the episode:

• Palliative Care

Additional LLS Support Resources: 

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Clinical Trial Support Center
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program 
• Free Nutrition Consultations 
• LLS Advocacy
• LLS Myeloma Link

Support for this episode provided by Bristol Myers Squibb; Genentech, Inc. & Biogen; Pharmacyclics LLC, An AbbVie Company & Janssen Biotech, Inc.